Investigación / Grupos de investigación

Grupo  2

Enfermedades Neurológicas

Publicaciones (386)

  • Gago-Veiga, AB; Lopez-Alcaide, N; Quintas, S; Lázaro, IF; Casas-Limón, J; Calle, C; Latorre, G; González-García, N; Porta-Etessam, J; Rodriguez-Vico, J; Jaimes, A; García, AG; García-Azorín, D; Guerrero-Peral, AL; Sierra, A; Ros, AL; Sánchez-Soblechero, A; Díaz-de-Teran, J; Membrilla, JA; Treviño, C; Gonzalez-Martinez, A.

    Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(5): [doi:10.1111/ene.16215]

  • del Rincón, CR; Gonzalez-Martinez, A; Quintas, S; García-Azorín, D; Lázaro, IF; Guerrero-Peral, AL; Osorio, YG; Santos-Lasaosa, S; Oria, CG; Rodríguez, NS; Díez, FI; Iñiguez, AE; Luque, SG; Huerta-Villanueva, M; Díaz, SC; Muñoz-Vendrell, A; Ros, AL; Sánchez-Soblechero, A; Juanes, FV; Kortazar-Zubizarreta, I; Echeverria, A; Rodríguez-Vico, J; Sánchez, AJ; Garcia, AG; Sánchez-Mateos, NM; Belvis, R; Pérez, MPN; García-Monco, JC; Escudero, MRA; Montes, N; Gago-Veiga, AB.

    RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(4): Nº de citas: 1 [doi:10.1111/ene.16203]

  • Haraldsen, IH; Hatlestad-Hall, C; Marra, C; Renvall, H; Maestu, F; Acosta-Hernandez, J; Alfonsin, S; Andersson, V; Anand, A; Ayllon, V; Babic, A; Belhadi, A; Birck, C; Bruna, R; Caraglia, N; Carrarini, C; Christensen, E; Cicchetti, A; Daugbjerg, S; Di Bidino, R; Diaz-Ponce, A; Drews, A; Giuffre, GM; Georges, J; Gil-Gregorio, P; Gove, D; Govers, TM; Hallock, H; Hietanen, M; Holmen, L; Hotta, J; Kaski, S; Khadka, R; Kinnunen, AS; Koivisto, AM; Kulashekhar, S; Larsen, D; Liljestroem, M; Lind, PG; Dolado, AM; Marshall, S; Merz, S; Miraglia, F; Montonen, J; Maentynen, V; Oksengard, AR; Olazaran, J; Paajanen, T; Pena, JM; Pena, L; Peniche, DL; Perez, AS; Radwan, M; Ramirez-Torano, F; Rodriguez-Pedrero, A; Saarinen, T; Salas-Carrillo, M; Salmelin, R; Sousa, S; Suyuthi, A; Toft, M; Toharia, P; Tveitstol, T; Tveter, M; Upreti, R; Vermeulen, RJ; Vecchio, F; Yazidi, A; Rossini, PM.

    Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

    Frontiers in Neurorobotics. 2024; 17: 1289406-1289406 Nº de citas: 7 [doi:10.3389/fnbot.2023.1289406]

  • Becerra-Fajardo, L; Minguillon, J; Krob, MO; Rodrigues, C; González-Sánchez, M; Megia-García, A; Galan, CR; Henares, FG; Comerma, A; del-Ama, AJ; Gil-Agudo, A; Grandas, F; Schneider-Ickert, A; Barroso, FO; Ivorra, A.

    First-in-human demonstration of floating EMG sensors and stimulators wirelessly powered and operated by volume conduction

    JOURNAL OF NEUROENGINEERING AND REHABILITATION. 2024; 21(1): Nº de citas: 1 [doi:10.1186/s12984-023-01295-5]

  • Oreja-Guevara, C; Martinez-Yélamos, S; Eichau, S; Llaneza, MA; Martín-Martínez, J; Peña-Martínez, J; Meca-Lallana, V; Alonso-Torres, AM; Moral-Torres, E; Río, J; Calles, C; Ares-Luque, A; Ramió-Torrentà, L; Marzo-Sola, ME; Prieto, JM; Martínez-Ginés, ML; Arroyo, R; Otano-Martínez, MA; Brieva-Ruiz, L; Gómez-Gutiérrez, M; Rodríguez-Antigüedad, A; Sánchez-Seco, V; Costa-Frossard, L; Hernández-Pérez, MA; Landete-Pascual, L; González-Platas, M; Meca-Lallana, JE.

    Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

    Therapeutic Advances in Neurological Disorders. 2024; 17: Nº de citas: 6 [doi:10.1177/17562864241284372]

  • Sánchez-Soblechero, A; López-García, S; Lage, C; Fernández-Matarrubia, M; Irure, J; López-Hoyos, M; Jiménez-Bonilla, J; Quirce, R; de Arcocha-Torres, M; Cuenca-Vera, O; Martín-Arroyo, J; Martínez-Dubarbie, F; Pozueta, A; García-Martínez, M; Infante, J; Sánchez-Juan, P; Rodríguez-Rodríguez, E.

    Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?

    JOURNAL OF ALZHEIMERS DISEASE. 2024; 98(3): 957-967 [doi:10.3233/JAD-230678]

  • Sanchez-Soblechero, A; Berbel, A; Villarejo, A; Palmi-Cortes, I; Vieira, A; Gil-Moreno, MJ; Fernandez, C; Martin-Montes, A; Carreras, MT; Fernandez, Y; Puertas, C; Blanco-Palmero, V; Llamas, S; Gonzalez-Sanchez, M; Lapena, T; de Luis, P; Manzano, S; Olazaran, J.

    Translating NIA-AA criteria into usual practice: Report from the ReDeMa Project

    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2024; 10(1): Nº de citas: 2 [doi:10.1002/trc2.12451]

  • Matias-Guiu, JA; González-Rosa, J; Hernández, MA; Martínez-Ginés, ML; Portolés, A; Pérez-Macías, N; Benito-León, J; Padrón, I; Prieto, J; Matias-Guiu, J.

    Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial

    BMJ Open. 2024; 14(1): Nº de citas: 2 [doi:10.1136/bmjopen-2023-078661]

  • Navalón, P; Merchan-Naranjo, J; Ghosn, F; Almansa, B; Chafer-Pericas, C; González-Peñas, J; Rodríguez-Toscano, E; Zeballos, S; Arriaga, M; Castro, PC; Bravo, DB; Vento, M; Pina-Camacho, L; García-Blanco, A.

    Study of the pathophysiological mechanisms associated with the onset and course of neurodevelopmental disorders in preterm infants (the PeriSTRESS-PremTEA study): Rationale, objectives, design and sample description

    SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2024; 17(1): 19-27 [doi:10.1016/j.rpsm.2021.02.002]

  • Epifani, F; Serra, SMP; Llorens, M; Balcells, S; Nolasco, G; Bolasell, M; Aguilera-Albesa, S; Candela, RC; Cervera, JLC; Sanchez, VG; Garcia, O; Miranda-Herrero, MC; Moreno-Lozano, PJ; Robles, B; Aparicio, SR; Fragua, RV; Serrano, M.

    Untangling adaptive functioning of PMM2-CDG across age and its impact on parental stress: a cross-sectional study

    Scientific Reports. 2023; 13(1): Nº de citas: 1 [doi:10.1038/s41598-023-49518-y]

  • Jiménez-Gonzalo, L; Vara-García, C; Romero-Moreno, R; Márquez-González, M; Olazarán, J; von Känel, R; Mausbach, BT; Losada-Baltar, A.

    An integrated model of psychosocial correlates of insomnia severity in family caregivers of people with dementia

    AGING & MENTAL HEALTH. 2023; 28(7): 969-976 [doi:10.1080/13607863.2023.2293052]

  • Amaya Pascasio L; De La Casa-Fages B; Esteban de Antonio E; Grandas F; García-Leal R; Ruiz Juretschke F.

    Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors.

    Neurologia (barcelona, Spain). 2023; 38(9): 625-634 [doi:10.1016/j.nrleng.2021.03.010]

  • Pascasio, LA; De la Casa-Fages, B; de Antonio, EE; Grandas, F; García-Leal, R; Juretschke, FR.

    Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors

    NEUROLOGIA. 2023; 38(9): 625-634 Nº de citas: 8 [doi:10.1016/j.nrl.2021.03.009]

  • Martínez-Rubio, D; Hinarejos, I; Argente-Escrig, H; Marco-Marín, C; Lozano, MA; Gorría-Redondo, N; Lupo, V; Martí-Carrera, I; Miranda, C; Vázquez-López, M; García-Pérez, A; Marco-Hernández, AV; Tomás-Vila, M; Aguilera-Albesa, S; Espinós, C.

    Genetic Heterogeneity Underlying Phenotypes with Early-Onset Cerebellar Atrophy

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(22): Nº de citas: 5 [doi:10.3390/ijms242216400]

  • Lozano-Ros, A; Martínez-Ginés, ML; García-Domínguez, JM; Salvador-Martín, S; Goicochea-Briceño, H; Cuello, JP; Meldaña-Rivera, A; Higueras-Hernández, Y; Sanjurjo-Sáez, M; Alvarez-Sala-Walther, LA; López-Fernández, LA.

    Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(19): Nº de citas: 5 [doi:10.3390/ijms241914447]

  • Domínguez-Mozo, MI; González-Suárez, I; Villar, LM; Costa-Frossard, L; Villarrubia, N; Aladro, Y; Pilo, B; Montalbán, X; Comabella, M; Casanova-Peno, I; Martínez-Ginés, ML; García-Domínguez, JM; García-Martínez, MA; Arroyo, R; Alvarez-Lafuente, R.

    Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology. 2023; 14: Nº de citas: 3 [doi:10.3389/fimmu.2023.1248182]

  • Benito-León, J; del Pino, AB; Aladro, Y; Cuevas, C; Domingo-Santos, A; Sánchez-Seco, VG; Labiano-Fontcuberta, A; Gómez-López, A; Salgado-Cámara, P; Costa-Frossard, L; Monreal, E; de la Maza, SS; Matías-Guiu, JA; Matías-Guiu, J; Delgado-Alvarez, A; Montero-Escribano, P; Martínez-Ginés, ML; Higueras, Y; Ayuso-Peralta, L; Malpica, N; Melero, H.

    Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study

    MULTIPLE SCLEROSIS JOURNAL. 2023; 29(11-12): 1393-1405 Nº de citas: 4 [doi:10.1177/13524585231195851]

  • Olazaran, J; Carnero-Pardo, C; Fortea, J; Sanchez-Juan, P; Garcia-Ribas, G; Vinuela, F; Martinez-Lage, P; Boada, M.

    Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact

    Alzheimers Research & Therapy. 2023; 15(1): Nº de citas: 3 [doi:10.1186/s13195-023-01271-0]